For GLP-1 drugs, the risks include: Increased anxiety or panic from unstable blood sugar Triggering or worsening depression Heightened risk of obsessive eating behaviors Potential for self-esteem issues or body image dysmorphia For someone already struggling with mental health, these risks are compounded making proper medical oversight essential
Unlike single-receptor agonists or dual agonists, this triagonist approach appears to produce synergistic effects on weight loss, glycemic control, and metabolic parameters through complementary pathway activation
The supplement industry profits from peoples desire for convenient solutions, but lasting weight management requires addressing eating behaviours, physical activity patterns, and the psychological factors that influence our relationship with food
Retatrutide treatment produces favorable shifts in lipid metabolism
[2] Experts suggest eating a balanced diet of nutrient-dense foods while using GLP-1 medications
GLP-1 also inhibits the production of glucagon from the pancreas